Table 1.

Demographics and main lobar hematoma-related variables

Patient #	Age/sex	Year*	Vascular risk factors	Antithrombotics	Side/location	Volume (mls)	Pathological material	MRI	Lobar ICH-related death
1	55/F	2015	HTN	No	L/frontal	27	HE	Yes	Yes
2	74/F	2017	HTN	No	L/occipital	32	HE	No	No
3	57/F	2017	HTN, NIDM	Heparin	R/fronto-parietal	38	HE	Yes	Yes
4	80/F	2018	HTN, DL	No	R/frontal	8	HE	Yes	No
5	76/F	2019	None	No	L/parietal	40	HE	Yes	No
6	67/F	2019	HTN	No	Parietal	35	HE	Yes	No
7	71/F	2019	None	No	L/frontal	89	HE	Yes	Yes
8	69/F	2019	HTN	No	R/temporal	40	HE	Yes	No
9	59/M	2010	HTN	No	L/temporo-occipital	20	HE	Yes	No
10	65/M	2013	DL	Aspirin	R/frontal	82	HE	Yes	No
11	60/M	2013	HTN, NIDM	Aspirin	Frontal	81	HE	No	Yes
12	67/F	1999	None	No	Frontal	26	HE	No	No
13	63/F	2004	None	Aspirin	Frontal	15	Autopsy	No	Yes
14	69/M	1999	NIDM	No	Frontal	60	HE	Yes	No
15	62/M	1999	DL	No	Frontal	74	HE	No	Yes
16	59/M	2006	HTN, smoking	No	Frontal	45	HE	Yes	No

^*: year the pathological material was available; F female, M male, HTN arterial hypertension, NIDM non-insulin dependent diabetes mellitus, DL dyslipidemia, L left, R right, HE hematoma evacuation